ALBEMARLE CORP

ALB · XNYS

CIK 915913fmd_0GNBTEN7M10VMEYQ2K4Y7B0X6TManufacturing · Plastic Materials, Synth Resins & Nonvulcan ElastomersTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2026, 71 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	2,677	3,072	3,375	3,589	3,129	3,328	7,320	9,617	5,378	5,143
Cost of revenue	1,707	1,966	2,158	2,332	2,134	2,330	4,246	8,431	5,315	4,474
Gross profit	970	1,106	1,217	1,258	995	998	3,075	1,186	63	669
Realized investment gains (losses)	–	–	–	–	–	–	0	0	(34)	0
Research and development	80	84	70	58	59	54	72	86	87	51
Selling, general and administrative	354	450	446	533	430	441	524	910	618	550
Gain on sale of real estate	–	0	0	14	0	0	–	–	–	–
Operating income	601	572	912	666	506	798	2,470	252	(1,777)	(367)
Interest expense	65	115	52	58	73	61	123	116	166	208
Other non-operating income (expense)	(21)	(10)	(64)	(45)	(59)	(603)	86	111	178	23
Income before taxes	515	447	795	563	374	134	2,433	247	(1,764)	(552)
Income tax expense	96	432	145	88	54	29	391	430	87	157
Net income from continuing operations	479	99	739	533	376	124	2,690	1,573	(1,851)	(709)
Net income	644	55	694	533	376	124	2,690	1,573	(1,179)	(511)
Net income to common shareholders	–	–	–	–	–	–	2,690	1,573	(1,316)	(677)